Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing a novel T-cell immunotherapy for multiple sclerosis , today reported financial results for the year more

View todays social media effects on OPXA

View the latest stocks trending across Twitter. Click to view dashboard

See who Opexa is hiring next, click here to view